Biocon Biologics obtains USFDA approval for biosimilar Aflibercept
Yesafili enters U.S. market to treat ophthalmology conditions
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Indoco Remedies gains USFDA approval for Pregabalin capsules
Generic version of Lyrica to be manufactured in Goa facility
Strides receives USFDA approval for Sucralfate Oral Suspension, 1gm/10 mL
Sucralfate is used to treat stomach ulcers, GERD, radiation proctitis, and stomach inflammation and to prevent stress ulcers.
Alvotech and Dr Reddy’s collaborate on biosimilar AVT03
Dr Reddy’s gets exclusive commercialisation rights of denosumab in the US as well as semi-exclusive rights in Europe and UK
Cipla gains USFDA approval for the generic version of Somatuline Depot (Lanreotide) injection
The new generic version to treat patients with GEP-NETs
AstraZeneca sets $80 billion revenue target by 2030
Company aims to launch 20 new medicines by 2030, and reduce carbon emissions
Sanofi, Formation Bio and OpenAI announce collaboration
The collaboration aim to build AI-powered software to accelerate drug development
Glenmark and BeiGene partner to market cancer drugs in India
Both the companies enter into an agreement for marketing and distribution of Tislelizumab and Zanubrutinib in India
The trailblazers among us: honouring India’s clinical research professionals
As we celebrate Clinical Trials Day with the 2024 theme, 'The Trailblazers Among Us', it's essential to recognise the remarkable…
SII ships its first set of R21/Matrix-M Malaria Vaccine doses to Africa
The initial shipment will be sent to the Central African Republic (CAR), followed by other African countries such as South Sudan…